The store will not work correctly when cookies are disabled.
(E)-3-(3-tert-butyl-4-hydroxy-5-((E)-(thiazol-2-ylimino)methyl)phenyl)-1-(furan-2-yl)prop-2-en-1-one
ID: ALA3260657
PubChem CID: 136498900
Max Phase: Preclinical
Molecular Formula: C21H20N2O3S
Molecular Weight: 380.47
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CC(C)(C)c1cc(/C=C/C(=O)c2ccco2)cc(/C=N/c2nccs2)c1O
Standard InChI: InChI=1S/C21H20N2O3S/c1-21(2,3)16-12-14(6-7-17(24)18-5-4-9-26-18)11-15(19(16)25)13-23-20-22-8-10-27-20/h4-13,25H,1-3H3/b7-6+,23-13+
Standard InChI Key: LGEYRXCDYFAJIX-IFYJTALQSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
17.8942 -21.9321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8931 -22.7516 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6011 -23.1606 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3108 -22.7511 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3080 -21.9285 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5994 -21.5232 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5969 -20.7060 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.0141 -21.5172 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7234 -21.9231 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.4295 -21.5119 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1748 -21.8444 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.7193 -21.2350 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.3080 -20.5288 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5094 -20.7018 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
18.6009 -23.9777 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3086 -24.3865 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3084 -25.2037 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0160 -25.6125 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.1864 -21.5236 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6005 -25.6121 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8521 -25.2819 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3051 -25.8890 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7135 -26.5969 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5129 -26.4271 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.4788 -21.9324 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1862 -20.7064 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4759 -21.1149 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
6 7 1 0
5 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 10 1 0
3 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
1 19 1 0
17 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 20 1 0
19 25 1 0
19 26 1 0
19 27 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 380.47 | Molecular Weight (Monoisotopic): 380.1195 | AlogP: 5.39 | #Rotatable Bonds: 5 |
Polar Surface Area: 75.69 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 8.94 | CX Basic pKa: 0.28 | CX LogP: 5.41 | CX LogD: 5.40 |
Aromatic Rings: 3 | Heavy Atoms: 27 | QED Weighted: 0.37 | Np Likeness Score: -0.93 |
References
1. Sashidhara KV, Rao KB, Kushwaha V, Modukuri RK, Verma R, Murthy PK.. (2014) Synthesis and antifilarial activity of chalcone-thiazole derivatives against a human lymphatic filarial parasite, Brugia malayi., 81 [PMID:24863844] [10.1016/j.ejmech.2014.05.029] |